← Back to all trials
Recruiting
NCT07596173
A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTpa) in Healthy Japanese Adolescents Aged 11 Years to <13 Years
Conditions: Diphtheria-Tetanus-acellular Pertussis Vaccines
Sex: All
Ages: 11 Years – 12 Years
Healthy volunteers: Yes
Phase: PHASE3
Enrollment: 90
Sponsor: GlaxoSmithKline
Location: GSK Investigational Site Fukuoka
Summary
The purpose of the study is to assess the immune response, reactogenicity and safety of a booster dose of dTpa vaccine 1 month after vaccination in healthy Japanese participants aged 11 to \
Eligibility Criteria
Inclusion Criteria:
* Participants and/or participants' parent(s)/ Legally acceptable representative(s) \[LAR(s)\], who, in the opinion of the investigator, can and will comply with the requirements of the protocol.
* Physical or digital informed assent obtained from the participant prior to performance of any study-specific procedure.
* Physical or digital informed consent obtained from the parent(s)/LAR(s) of the participant prior to performance of any study-specific procedure.
* Healthy participants as established by medical history and clinical examination at screening.
* Male/female participant between and including 11 and \
Source: ClinicalTrials.gov (NCT07596173). StuddyBuddy aggregates publicly available trial information.